Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q83940125)
Watch
English
Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective
scientific article published on 29 March 2010
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
title
Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
author
Alexander Claviez
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
author name string
N Schub
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
A Günther
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
A Schrauder
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
C Ehlert
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
M Gramatzki
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
R Repp
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
publication date
29 March 2010
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
published in
Bone Marrow Transplantation
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
volume
46
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
issue
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
page(s)
143-147
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
exact match
https://scigraph.springernature.com/pub.10.1038/bmt.2010.68
0 references
cites work
Current and novel therapies in acute GVHD.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2010.68
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2010.68
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2010.68
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2010.68
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A review of Campath in autoimmune disease: biologic therapy in the gray zone between immunosuppression and immunoablation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2010.68
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2010.68
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Successful use of Campath-1H in the treatment of steroid refractory liver GvHD.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2010.68
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alemtuzumab can successfully treat steroid-refractory acute graft-versus-host disease (aGVHD)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2010.68
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2010.68
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alemtuzumab-induced resolution of refractory cutaneous chronic graft-versus-host disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2010.68
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alemtuzumab as treatment of steroid-refractory acute graft-versus-host disease: results of a phase II study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2010.68
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Successful treatment of severe acute intestinal graft-versus-host resistant to systemic and topical steroids with alemtuzumab
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FBMT.2010.68
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/BMT.2010.68
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
Dimensions Publication ID
1049666092
0 references
PubMed publication ID
20348971
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20348971
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20348971%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit